Showing results (71-80 of 254) with videos related to
Sort By:
Pageof 26
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 5, 2022
Evaluation of HIV-1 integrase variability by combining computational and probabilistic approachesDavide Vergni, Daniele Santoni, Yagai Bouba, et al.AIDS Reviews|May 19, 2011
European recommendations for the clinical use of HIV drug resistance testing: 2011 updateAnne-Mieke Vandamme, Ricardo J Camacho, Francesca Ceccherini-Silberstein, et al.The Journal of Antimicrobial Chemotherapy|July 13, 2014
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failureGabriella Rozera, Isabella Abbate, Emanuela Giombini, et al.Antiviral Therapy|May 17, 2007
The V118I mutation as a marker of advanced HIV infection and disease progressionMauro Zaccarelli, Valerio Tozzi, Patrizia Lorenzini, et al.Microbiology Spectrum|November 17, 2021
SARS-CoV-2 Variants and Their Relevant Mutational Profiles: Update Summer 2021Mohammad Alkhatib, Valentina Svicher, Romina Salpini, et al.The Journal of Antimicrobial Chemotherapy|May 27, 2014
Comparative replication capacity of raltegravir-resistant strains and antiviral activity of the new-generation integrase inhibitor dolutegravir in human primary macrophages and lymphocytesMichela Pollicita, Matteo Surdo, Fabiola Di Santo, et al.The Journal of Antimicrobial Chemotherapy|April 9, 2014
New raltegravir resistance pathways induce broad cross-resistance to all currently used integrase inhibitorsIsabelle Malet, Laura Gimferrer Arriaga, Anna Artese, et al.Journal of Virology|July 30, 2005
High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutationsFrancesca Ceccherini-Silberstein, Federico Gago, Maria Santoro, et al.AIDS (London, England)|July 29, 2004
Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressureFrancesca Ceccherini-Silberstein, Fulvio Erba, Federico Gago, et al.Molecular Pharmacology|April 19, 2005
The amino acid Asn136 in HIV-1 reverse transcriptase (RT) maintains efficient association of both RT subunits and enables the rational design of novel RT inhibitorsJan Balzarini, Joeri Auwerx, Fátima Rodríguez-Barrios, et al.Pageof 26